Delivery Order SPE2DB20D3303-SPE2DB25FZ9E4
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,445.20 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The product will be delivered to the company's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $11,570.41 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $26,154.01 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, non-set-aside contract employs firm fixed pricing with an ultimate completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with performance taking place at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,244.48 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. This firm fixed-price, competitively awarded contract carries an ultimate completion date of June 20, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $3,660.14 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a completion date of September 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,570.23 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of May 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $18,840.44 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. The delivery order represents a fulfillment under the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $114,066.75 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,731.88 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a child delivery order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,506.64 for Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement. The award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain, delivering this diabetes management medication to support military and veteran...